+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Bionano Genomics

(NASDAQ:BNGO)

Intraday

$0.87

0.005[0.58%]

After-Hours

$0.87

0[0.00%]

Perks Buy Compare Brokers

$0.87

0.005[0.58%]

At close: Apr 30

$0.87

0[0.00%]

After Hours: 6:11PM EDT

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Bionano Genomics Stock (NASDAQ:BNGO)

Bionano Genomics Stock (NASDAQ: BNGO)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 24, 2024

Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing
Benzinga Newsdesk - 6 days ago

Wednesday, April 17, 2024

Bionano Enters OEM Partnership With Diagens To Commercialize A Clinical Cytogenetic Analysis That Combines OGM And Artificial Intelligence
Benzinga Newsdesk - Apr 17, 2024, 8:03AM

Thursday, April 11, 2024

Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing
Benzinga Newsdesk - Apr 11, 2024, 8:16AM

Thursday, April 04, 2024

Bionano Announces $10M Registered Direct Offering At $1.02/Share
Benzinga Newsdesk - Apr 4, 2024, 1:48PM

Wednesday, April 03, 2024

Bionano Published Study Showing That OGM Identifies Genetic Aberrations In Sarcoma Samples That May Lead To Improved Diagnosis But Were Missed By Classical Cytogenetics
Benzinga Newsdesk - Apr 3, 2024, 8:14AM

Tuesday, March 19, 2024

Bionano Announces Publication Of A Breast Cancer Study Showing That The Number Of SVs Detected With OGM May Be Related To Prognosis, Tumor Progression And Chemotherapy Resistance
Benzinga Newsdesk - Mar 19, 2024, 8:15AM

Thursday, March 07, 2024

Scotiabank Maintains Sector Outperform on Bionano Genomics, Lowers Price Target to $6
Benzinga Newsdesk - Mar 7, 2024, 8:43AM

Tuesday, March 05, 2024

Bionano Genomics Sees Q1 Revenue $8.25M-$8.75M Vs $9.69M Est.; FY24 Revenue $37M-$41M Vs $47.17M Est.
Benzinga Newsdesk - Mar 5, 2024, 4:50PM
Bionano Genomics Q4 Sales $10.721M Beat $10.585M Estimate
Benzinga Newsdesk - Mar 5, 2024, 4:18PM
Earnings Scheduled For March 5, 2024
Benzinga Insights - Mar 5, 2024, 5:00AM

Monday, March 04, 2024

Earnings Outlook For Bionano Genomics
Benzinga Insights - Mar 4, 2024, 1:03PM

Friday, January 26, 2024

How Is The Market Feeling About Bionano Genomics?
Benzinga Insights - Jan 26, 2024, 9:30AM

Wednesday, January 24, 2024

Bionano Publishes Interim Readout From Second Phase Of Clinical Trial Analyzing Optical Genome Mapping As Standard Of Care For Prenatal Testing
Benzinga Newsdesk - Jan 24, 2024, 8:13AM

Tuesday, January 23, 2024

Bionano Announces Full Commercial Release Of The Stratys System For High Throughput Optical Genome Mapping
Benzinga Newsdesk - Jan 23, 2024, 8:13AM

Thursday, January 11, 2024

Bionano Announces Peer-Reviewed Publication From Its Clinical Study Designed To Support OGM As Part Of Standard Of Care In Genetic Disease Testing
Benzinga Newsdesk - Jan 11, 2024, 4:04PM

Monday, January 08, 2024

Bionano Reports Preliminary Q4 And FY23 Results; Sees Q4 Revenue $10.4M-$10.7M Vs $10.54M Est.; FY23 Revenue $35.8M-$36.1M Vs $35.94M Est.; Achieved All Full-Year 2023 ELEVATE Milestones
Benzinga Newsdesk - Jan 8, 2024, 8:13AM

Wednesday, January 03, 2024

Bionano Laboratories Announced The Publication Of The First Framework Paper For The Clinical Adoption And Implementation Of The Optical Genome Mapping Workflow For Hematological Malignancy Applications
Benzinga Newsdesk - Jan 3, 2024, 8:51AM

Tuesday, December 26, 2023

Bionano Announces Publication Of Largest Prospective Prenatal Study Comparing OGM To Chromosomal Microarray Analysis And Karyotyping
Happy Mohamed - Dec 26, 2023, 8:13AM

Thursday, December 14, 2023

Bionano Genomics Announces Cancers Journal Publishes Special Issue Dedicated To OGM's Impact On Hematological Malignancy Research
Benzinga Newsdesk - Dec 14, 2023, 8:17AM

Tuesday, December 12, 2023

Bionano Laboratories Announces Publication Of The Analytical Validation Of Its OGM-Based Laboratory Developed Test For Hematological Malignancies And Additional Multi-Site Technical Evaluation Of OGM
Benzinga Newsdesk - Dec 12, 2023, 8:22AM

Wednesday, December 06, 2023

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research At The American Society Of Hematology Annual Meeting
Benzinga Newsdesk - Dec 6, 2023, 8:13AM

Wednesday, November 29, 2023

Bionano Announces Publication Demonstrating Utility Of OGM To Assess Genome Integrity Of CRISPR-Edited Cells As Part Of Gene Therapy Development
Benzinga Newsdesk - Nov 29, 2023, 10:10AM

Thursday, November 16, 2023

Watching Axos Financial; The Bear Cave Newsletter Issues Report On Co Titled "Problems At Axos Financial (AX)"
Benzinga Newsdesk - Nov 16, 2023, 10:34AM

Tuesday, November 14, 2023

Bionano Announces Presentation Of OGM Utility Across Key Research Applications At The Association For Molecular Pathology Annual Meeting
Benzinga Newsdesk - Nov 14, 2023, 8:12AM

Monday, November 13, 2023

Maxim Group Downgrades Bionano Genomics to Hold
Benzinga Newsdesk - Nov 13, 2023, 7:55AM

Wednesday, November 08, 2023

Bionano Genomics: Q3 Earnings Insights
Benzinga Insights - Nov 8, 2023, 4:25PM
Bionano Genomics Q3 2023 Adj EPS $(1.01) Misses $(0.94) Estimate, Sales $9.32M Beat $8.98M Estimate
Benzinga Newsdesk - Nov 8, 2023, 4:25PM
Earnings Scheduled For November 8, 2023
Benzinga Insights - Nov 8, 2023, 4:21AM

Tuesday, November 07, 2023

A Preview Of Bionano Genomics's Earnings
Benzinga Insights - Nov 7, 2023, 1:02PM

Thursday, October 26, 2023

Bionano Announces Presentation Of OGM Utility Across Key Applications At the American Society Of Human Genetics Annual Meeting
Benzinga Newsdesk - Oct 26, 2023, 8:13AM

Wednesday, October 11, 2023

Bionano Prices $80M Financing In Convertible Notes And Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan; Sees Q3 Revenue $9.1M-$9.3M Vs $8.98M Est.
Benzinga Newsdesk - Oct 11, 2023, 8:06AM

Thursday, October 05, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Oct 5, 2023, 1:22PM

Wednesday, October 04, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Oct 4, 2023, 12:01PM

Thursday, September 21, 2023

Chief Financial Officer at Bionano Genomics Acquires Company Stock Options Worth 106,000 Shares
Benzinga Insights - Sep 21, 2023, 11:02AM
Bionano Announces Third OEM Partner Has Received China NMPA Approval For DNA Isolation Products For IVD Use Of OGM
Benzinga Newsdesk - Sep 21, 2023, 8:04AM

Tuesday, September 19, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Sep 19, 2023, 12:50PM

Wednesday, September 06, 2023

Bionano Announces Peer-Reviewed Publication On The Utility Of Combining OGM And WES For Evaluation Of Pediatric Leukemia
Happy Mohamed - Sep 6, 2023, 8:14AM

Wednesday, August 30, 2023

Bionano Announces Publication Demonstrating Utility Of OGM As An Alternative To KT And CMA For Evaluating CRISPR-Edited Cells As Part Of Stem Cell Therapy Development
Happy Mohamed - Aug 30, 2023, 8:15AM

Monday, August 28, 2023

Bionano Genomics' Chinese Original Equipment Manufacturing Partner, A-smart Medtech Has Obtained Reagent Class I Registrations From China's National Medical Products Administration For Bionano's DNA Extraction Kit And Labeling Products
Benzinga Newsdesk - Aug 28, 2023, 8:03AM

Monday, August 21, 2023

Bionano Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
Benzinga Newsdesk - Aug 21, 2023, 4:06PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM
Bionano Appoints Gülsen Kama As CFO, Effective September 11, 2023
Benzinga Newsdesk - Aug 14, 2023, 8:02AM

Friday, August 11, 2023

Bionano Announces Presentation Of Optical Genome Mapping Utility Across Cancer Research Applications At The Cancer Genomics Consortium 2023 Annual Meeting
Benzinga Newsdesk - Aug 11, 2023, 8:09AM

Thursday, August 10, 2023

BTIG Maintains Buy on Bionano Genomics, Raises Price Target to $10
Benzinga Newsdesk - Aug 10, 2023, 3:42PM
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Aug 10, 2023, 1:43PM

Wednesday, August 09, 2023

Bionano Genomics Q2 EPS $(1.24) Misses $(1.03) Estimate, Sales $8.66M Beat $8.29M Estimate
Benzinga Newsdesk - Aug 9, 2023, 4:43PM
Earnings Scheduled For August 9, 2023
Benzinga Insights - Aug 9, 2023, 4:54AM

Tuesday, August 08, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Aug 8, 2023, 1:32PM

Monday, August 07, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 7, 2023, 12:13PM
What's Going On With Bionano Genomics Stock?
Erica Kollmann - Aug 7, 2023, 10:07AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved